ID   PMM1_HUMAN              Reviewed;         262 AA.
AC   Q92871; A8K003; Q92586;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   15-MAR-2017, entry version 159.
DE   RecName: Full=Phosphomannomutase 1;
DE            Short=PMM 1;
DE            EC=5.4.2.8;
DE   AltName: Full=PMMH-22;
GN   Name=PMM1; Synonyms=PMMH22;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=9070917; DOI=10.1006/geno.1996.4536;
RA   Matthijs G., Schollen E., Pirard M., Budarf M.L., van Schaftingen E.,
RA   Cassiman J.-J.;
RT   "PMM (PMM1), the human homologue of SEC53 or yeast phosphomannomutase,
RT   is localized on chromosome 22q13.";
RL   Genomics 40:41-47(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9119384; DOI=10.1006/geno.1996.4487;
RA   Wada Y., Sakamoto M.;
RT   "Isolation of the human phosphomannomutase gene (PMM1) and assignment
RT   to chromosome 22q13.";
RL   Genomics 39:416-417(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RA   Hansen S.H., Frank S.R., Casanova J.E.;
RL   Submitted (FEB-1997) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skeletal muscle;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) IN COMPLEX WITH MAGNESIUM IONS
RP   AND MANNOSE 1-PHOSPHATE, FUNCTION, ACTIVE SITE, COFACTOR, SUBUNIT, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=16540464; DOI=10.1074/jbc.M601505200;
RA   Silvaggi N.R., Zhang C., Lu Z., Dai J., Dunaway-Mariano D.,
RA   Allen K.N.;
RT   "The X-ray crystal structures of human alpha-phosphomannomutase 1
RT   reveal the structural basis of congenital disorder of glycosylation
RT   type 1a.";
RL   J. Biol. Chem. 281:14918-14926(2006).
CC   -!- FUNCTION: Involved in the synthesis of the GDP-mannose and
CC       dolichol-phosphate-mannose required for a number of critical
CC       mannosyl transfer reactions. In addition, may be responsible for
CC       the degradation of glucose-1,6-bisphosphate in ischemic brain.
CC       {ECO:0000269|PubMed:16540464}.
CC   -!- CATALYTIC ACTIVITY: Alpha-D-mannose 1-phosphate = D-mannose 6-
CC       phosphate.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:16540464};
CC   -!- ENZYME REGULATION: IMP, a metabolite whose concentration is
CC       elevated in anoxia, inhibits phosphomannomutase and
CC       phosphoglucomutase activities and strongly enhances glucose-1,6-
CC       bisphosphatase activity. {ECO:0000250}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=54 uM for alpha-D-mannose 1-phosphate
CC         {ECO:0000269|PubMed:16540464};
CC         KM=7.5 uM for alpha-D-glucose 1-phosphate
CC         {ECO:0000269|PubMed:16540464};
CC   -!- PATHWAY: Nucleotide-sugar biosynthesis; GDP-alpha-D-mannose
CC       biosynthesis; alpha-D-mannose 1-phosphate from D-fructose 6-
CC       phosphate: step 2/2.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:16540464}.
CC   -!- INTERACTION:
CC       P20340:RAB6A; NbExp=4; IntAct=EBI-746784, EBI-1052826;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- TISSUE SPECIFICITY: Strong expression in liver, heart, brain, and
CC       pancreas; lower expression in skeletal muscle.
CC   -!- SIMILARITY: Belongs to the eukaryotic PMM family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U62526; AAC51117.1; -; mRNA.
DR   EMBL; D87810; BAA13460.1; -; mRNA.
DR   EMBL; U86070; AAC00023.1; -; mRNA.
DR   EMBL; CR456544; CAG30430.1; -; mRNA.
DR   EMBL; AK289368; BAF82057.1; -; mRNA.
DR   EMBL; AK316580; BAG38168.1; -; mRNA.
DR   EMBL; AL023553; CAB46025.1; -; Genomic_DNA.
DR   EMBL; CH471095; EAW60443.1; -; Genomic_DNA.
DR   EMBL; BC010855; AAH10855.1; -; mRNA.
DR   EMBL; BC016818; AAH16818.1; -; mRNA.
DR   CCDS; CCDS14020.1; -.
DR   RefSeq; NP_002667.2; NM_002676.2.
DR   UniGene; Hs.75835; -.
DR   PDB; 2FUC; X-ray; 2.10 A; A=1-262.
DR   PDB; 2FUE; X-ray; 1.75 A; A=1-262.
DR   PDBsum; 2FUC; -.
DR   PDBsum; 2FUE; -.
DR   ProteinModelPortal; Q92871; -.
DR   SMR; Q92871; -.
DR   BioGrid; 111385; 13.
DR   IntAct; Q92871; 6.
DR   MINT; MINT-1482037; -.
DR   STRING; 9606.ENSP00000216259; -.
DR   DEPOD; Q92871; -.
DR   iPTMnet; Q92871; -.
DR   PhosphoSitePlus; Q92871; -.
DR   BioMuta; PMM1; -.
DR   DMDM; 2499519; -.
DR   EPD; Q92871; -.
DR   MaxQB; Q92871; -.
DR   PaxDb; Q92871; -.
DR   PeptideAtlas; Q92871; -.
DR   PRIDE; Q92871; -.
DR   DNASU; 5372; -.
DR   Ensembl; ENST00000216259; ENSP00000216259; ENSG00000100417.
DR   GeneID; 5372; -.
DR   KEGG; hsa:5372; -.
DR   UCSC; uc003bal.3; human.
DR   CTD; 5372; -.
DR   DisGeNET; 5372; -.
DR   GeneCards; PMM1; -.
DR   HGNC; HGNC:9114; PMM1.
DR   HPA; HPA030712; -.
DR   MIM; 601786; gene.
DR   neXtProt; NX_Q92871; -.
DR   OpenTargets; ENSG00000100417; -.
DR   PharmGKB; PA33440; -.
DR   eggNOG; KOG3189; Eukaryota.
DR   eggNOG; COG0561; LUCA.
DR   GeneTree; ENSGT00390000002918; -.
DR   HOGENOM; HOG000181843; -.
DR   HOVERGEN; HBG009971; -.
DR   InParanoid; Q92871; -.
DR   KO; K17497; -.
DR   OMA; NDYEIYD; -.
DR   OrthoDB; EOG091G0J2S; -.
DR   PhylomeDB; Q92871; -.
DR   TreeFam; TF300874; -.
DR   BRENDA; 5.4.2.8; 2681.
DR   Reactome; R-HSA-446205; Synthesis of GDP-mannose.
DR   UniPathway; UPA00126; UER00424.
DR   EvolutionaryTrace; Q92871; -.
DR   GeneWiki; PMM1; -.
DR   GenomeRNAi; 5372; -.
DR   PRO; PR:Q92871; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000100417; -.
DR   CleanEx; HS_PMM1; -.
DR   ExpressionAtlas; Q92871; baseline and differential.
DR   Genevisible; Q92871; HS.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004615; F:phosphomannomutase activity; IDA:UniProtKB.
DR   GO; GO:0009298; P:GDP-mannose biosynthetic process; TAS:Reactome.
DR   GO; GO:0006013; P:mannose metabolic process; IDA:UniProtKB.
DR   GO; GO:0006487; P:protein N-linked glycosylation; IBA:GO_Central.
DR   GO; GO:0045047; P:protein targeting to ER; IBA:GO_Central.
DR   Gene3D; 3.40.50.1000; -; 2.
DR   InterPro; IPR023214; HAD-like_dom.
DR   InterPro; IPR006379; HAD-SF_hydro_IIB.
DR   InterPro; IPR005002; PMM.
DR   PANTHER; PTHR10466; PTHR10466; 1.
DR   Pfam; PF03332; PMM; 1.
DR   SFLD; SFLDG01143; C2.B.3:_Phosphomannomutase_Lik; 1.
DR   SUPFAM; SSF56784; SSF56784; 1.
DR   TIGRFAMs; TIGR01484; HAD-SF-IIB; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm; Isomerase;
KW   Magnesium; Metal-binding; Phosphoprotein; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    262       Phosphomannomutase 1.
FT                                /FTId=PRO_0000199692.
FT   ACT_SITE     19     19       Nucleophile.
FT                                {ECO:0000269|PubMed:16540464}.
FT   ACT_SITE     21     21       Proton donor/acceptor. {ECO:0000255}.
FT   METAL        19     19       Magnesium.
FT   METAL        21     21       Magnesium; via carbonyl oxygen.
FT   METAL       218    218       Magnesium.
FT   BINDING      28     28       Substrate.
FT   BINDING     132    132       Substrate.
FT   BINDING     143    143       Substrate.
FT   BINDING     150    150       Substrate.
FT   BINDING     186    186       Substrate; via amide nitrogen.
FT   BINDING     188    188       Substrate.
FT   BINDING     190    190       Substrate.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES     242    242       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35621}.
FT   CONFLICT     11     11       K -> R (in Ref. 1; AAC51117).
FT                                {ECO:0000305}.
FT   CONFLICT    169    169       A -> D (in Ref. 1; AAC51117).
FT                                {ECO:0000305}.
FT   STRAND       14     21       {ECO:0000244|PDB:2FUE}.
FT   TURN         22     24       {ECO:0000244|PDB:2FUE}.
FT   HELIX        33     42       {ECO:0000244|PDB:2FUE}.
FT   TURN         43     45       {ECO:0000244|PDB:2FUE}.
FT   STRAND       46     51       {ECO:0000244|PDB:2FUE}.
FT   HELIX        56     63       {ECO:0000244|PDB:2FUE}.
FT   TURN         66     68       {ECO:0000244|PDB:2FUE}.
FT   HELIX        69     72       {ECO:0000244|PDB:2FUE}.
FT   STRAND       74     78       {ECO:0000244|PDB:2FUE}.
FT   HELIX        79     81       {ECO:0000244|PDB:2FUE}.
FT   STRAND       83     86       {ECO:0000244|PDB:2FUE}.
FT   STRAND       89     91       {ECO:0000244|PDB:2FUC}.
FT   HELIX        96    100       {ECO:0000244|PDB:2FUE}.
FT   HELIX       102    117       {ECO:0000244|PDB:2FUE}.
FT   STRAND      128    131       {ECO:0000244|PDB:2FUE}.
FT   STRAND      136    138       {ECO:0000244|PDB:2FUE}.
FT   HELIX       147    160       {ECO:0000244|PDB:2FUE}.
FT   HELIX       162    173       {ECO:0000244|PDB:2FUE}.
FT   TURN        174    176       {ECO:0000244|PDB:2FUE}.
FT   STRAND      179    182       {ECO:0000244|PDB:2FUE}.
FT   STRAND      185    187       {ECO:0000244|PDB:2FUE}.
FT   STRAND      189    193       {ECO:0000244|PDB:2FUE}.
FT   HELIX       198    201       {ECO:0000244|PDB:2FUE}.
FT   HELIX       202    205       {ECO:0000244|PDB:2FUE}.
FT   TURN        206    209       {ECO:0000244|PDB:2FUC}.
FT   STRAND      211    218       {ECO:0000244|PDB:2FUE}.
FT   HELIX       227    231       {ECO:0000244|PDB:2FUE}.
FT   STRAND      235    239       {ECO:0000244|PDB:2FUE}.
FT   HELIX       243    254       {ECO:0000244|PDB:2FUE}.
SQ   SEQUENCE   262 AA;  29747 MW;  1FBA7BFC9C3BB0BB CRC64;
     MAVTAQAARR KERVLCLFDV DGTLTPARQK IDPEVAAFLQ KLRSRVQIGV VGGSDYCKIA
     EQLGDGDEVI EKFDYVFAEN GTVQYKHGRL LSKQTIQNHL GEELLQDLIN FCLSYMALLR
     LPKKRGTFIE FRNGMLNISP IGRSCTLEER IEFSELDKKE KIREKFVEAL KTEFAGKGLR
     FSRGGMISFD VFPEGWDKRY CLDSLDQDSF DTIHFFGNET SPGGNDFEIF ADPRTVGHSV
     VSPQDTVQRC REIFFPETAH EA
//
